Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB+ CD8+ T-cell infiltration.
about
Immunotherapy of Metastatic Colorectal Cancer: Prevailing Challenges and New Perspectives.Local production of the chemokines CCL5 and CXCL10 attracts CD8+ T lymphocytes into esophageal squamous cell carcinoma.An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancerCXCR3 as a molecular target in breast cancer metastasis: inhibition of tumor cell migration and promotion of host anti-tumor immunity.Altered phenotypic and functional characteristics of CD3+CD56+ NKT-like cells in human gastric cancer.Recombinant oncolytic poliovirus, PVSRIPO, has potent cytotoxic and innate inflammatory effects, mediating therapy in human breast and prostate cancer xenograft models.Prediction of biomarkers of oral squamous cell carcinoma using microarray technology.Human Tumor-Infiltrating Myeloid Cells: Phenotypic and Functional Diversity.Treatment with the C-C chemokine receptor type 5 (CCR5)-inhibitor maraviroc suppresses growth and induces apoptosis of acute lymphoblastic leukemia cells.Increased T-cell Infiltration Elicited by Erk5 Deletion in a Pten-Deficient Mouse Model of Prostate Carcinogenesis.MiR-15a-5p negatively regulates cell survival and metastasis by targeting CXCL10 in chronic myeloid leukemia.Targeting autophagy inhibits melanoma growth by enhancing NK cells infiltration in a CCL5-dependent manner.Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3.Therapeutic cancer vaccines.Strategy to targeting the immune resistance and novel therapy in colorectal cancer.
P2860
Q36114649-374182CE-A59A-440F-811B-FD2B4B918A52Q36413088-B4ACB56A-8B4A-446A-AC67-1AC02C38381AQ36544900-F0159BC2-9E26-432F-815B-F72CBAA8130DQ36685419-63A3A33A-D452-4E74-B7C4-74FBE3C35D79Q37688225-0A1BD6EB-BEF0-4F02-8CEB-01B29A573709Q37694857-C0D1B14D-B44F-4DEB-9556-05E04F60F809Q38972669-98E5FB31-E62B-4290-B1EF-72BB823EC50BQ39144794-F5C2C5CF-10AE-44D9-A6C8-8C2AA34A2130Q41999646-2B1093DF-E125-4784-8C0F-91B33D340FF5Q42051316-9A6B1EF8-51C8-4BA3-B614-E51F84C5B2BBQ42068004-E84C3D0A-DA98-4CCB-A073-EB1A748003DBQ47129350-6C394397-D49E-4A03-B201-D11CEC081D06Q47719808-2E6610A7-38B1-4220-A5D4-B86BA3AE065AQ50988785-41E685F1-5473-451C-AF4D-DB5A02554EA7Q52320729-A3B07276-8EA6-41A8-9DB5-18C9EA3E2EDF
P2860
Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB+ CD8+ T-cell infiltration.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Active secretion of CXCL10 and ...... meB+ CD8+ T-cell infiltration.
@ast
Active secretion of CXCL10 and ...... meB+ CD8+ T-cell infiltration.
@en
type
label
Active secretion of CXCL10 and ...... meB+ CD8+ T-cell infiltration.
@ast
Active secretion of CXCL10 and ...... meB+ CD8+ T-cell infiltration.
@en
prefLabel
Active secretion of CXCL10 and ...... meB+ CD8+ T-cell infiltration.
@ast
Active secretion of CXCL10 and ...... meB+ CD8+ T-cell infiltration.
@en
P2093
P2860
P356
P1433
P1476
Active secretion of CXCL10 and ...... meB+ CD8+ T-cell infiltration.
@en
P2093
C Richard Boland
Mildred Arnold
Timothy J Zumwalt
P2860
P304
P356
10.18632/ONCOTARGET.3205
P407
P50
P577
2015-02-01T00:00:00Z